Andrew D. C. LaFrence
Overview
Andrew D. C. LaFrence received $674K in total compensation, including $244K in salary, at Cancer Genetics in 2021. Andrew LaFrence also received an average of $649K at SurModics from 2013 to 2015.
Source: SEC filings on June 14, 2022 and January 8, 2016.
Related executives
We found 19 more executives who work or worked at Cancer Genetics and SurModics.
John Roberts
Cancer Genetics
Chief Executive Officer
Yung-Ping Yeh
Cancer Genetics
Chief Information Officer
Ralf Brandt
Cancer Genetics
President, Discovery & Early Development Services
Gary Maharaj
SurModics
Chief Executive Officer
Teryl Sides
SurModics
Chief Marketing Officer
Bryan Phillips
SurModics
General Counsel
Thomas Greaney
SurModics
Chief Operating Officer
Timothy Arens
SurModics